Wolfram Samlowski
oncologist
≈ 3 min read
Names in other languages
- ItalianoWolfram Samlowski, M.D.
- DeutschWolfram Samlowski
- EnglishWolfram Samlowski
- EspañolWolfram Samlowski
- FrançaisWolfram Samlowski
- NederlandsWolfram Samlowski
- PortuguêsWolfram Samlowski
- slWolfram Samlowski
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Wolfram Samlowski (born August 16, 1954) is an American medical oncologist with Nevada Oncology Specialists. His research interests include translational research and development of novel cancer immunotherapy agents, translational drug development.
His clinical interests are in developing more effective treatments for advanced stages of melanoma and non-melanoma skin cancers (such as squamous cell and basal cell, skin cancer, merkel cell carcinoma), and sarcoma.
Published works
Natl. Cooperative Oncology Group Clinical Trial Authorship Evaluation of biologic markers that may predict sensitivity or resistance of recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) to phase II chemotherapy agents: Pathology ancillary study (SWOG 9807). Primary study coordinator.
Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)(SWOG 9902). Primary study coordinator. Evaluation of 3-hour infusion of paclitaxel plus cisplatin and 5-fluorouracil in patients with advanced/recurrent squamous cell carcinoma of the head and neck (SCCHN): Phase II (S0007).
Co-investigator. A Phase II trial of imatinib mesylate (Gleevec) in neuroendocrine carcinoma of the skin (Merkel Cell Carcinoma) (S0331). Primary study coordinator.
Peer-reviewed publications
Samlowski WE, Kondapaneni M, McGregor JR, Tharkar, S, Laubach VE, Salvemini D. Endothelial nitric oxide synthase (eNOS) is a key mediator of interleukin-2 (IL-2) induced hypotension and vascular leak syndrome. J Immunother 34:419-27, 2011. Eroglu Z, Kong M, Jakowatz JG, Akerly W, Samlowski W, Fruehauf JP.
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma. (in press, Cancer Chemother Pharmacol). Donepudi S, DeConti R, Samlowski WE.
Recent advances in understanding the genetics etiology and treatment of Merkel cell carcinoma. (in press, Seminars in Oncology). Samlowski EE, Dechet C, Weissman A, Samlowski WE.
Large cell non-Hodgkin’s lymphoma masquerading as renal carcinoma with IVC thrombosis: A case report. (in press, Journal of Medical Case Reports).
Book chapters, reviews, editorials and letters to editor
Eroglu Z, Kong M, Jakowatz JG, Akerly W, Samlowski W, Fruehauf JP. “Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma.” Cancer Chemother Pharmacol 68:1081-1087, 2011 Wong B, Samlowski WE.
Renal Cancer. In "Medical Therapy in Urology", Springer-Verlag, 2010. pp 17–31 Samlowski WE, Becker J. The Potential for Targeted Therapy of Merkel Cell Carcinoma. In Merkel Cell Carcinoma: A Multidisciplinary Approach by Sondak VK, Messina JL, Zager JS, Deconti RC, editors, Imperial College Press, London, United Kingdom 2010.
Fawaz S, Samlowski WE. A commentary on current management strategies for brain metastases from "radioresistant" tumors. In Brain Metastases: Symptoms, Diagnosis and Treatment.
(In press), Nova Science Publishers 2010. Loudyi A, Samlowski WE. Brain metastases from clear cell renal cancer.
In: Tumors of the central nervous system. Hayat MA, ed. In press, Springer, New York 2010. Gonsalves-Shapiro D, Samlowski WE.
Management of melanoma brain metastases in the era of targeted therapy. In: Melanoma: From Research to Treatment, Ascierto, PA, Kirkwood, JA, Marincola F, Palmieri G., eds, Hinawi, New York, (in press).
In the media
Avoiding doctors? Price of that decision may surprise you. Las Vegas Review-Journal, April 1, 2013 New Drug Treats Advanced Melanoma. KLAS-TV Las Vegas, November 15, 2011
External links
Nevada Oncology Specialists homepage
Text derived from https://en.wikipedia.org/w/index.php?oldid=1361656245 under CC BY-SA 4.0; modifications have been made.
References
1 claim could not be tied to a specific sentence and is listed in the table below instead.